Healthcare BPO Market Size to Hit Around US$ 755.76 billion by 2030

Precedence Research a new report on healthcare BPO market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future. The global healthcare BPO market size was valued at US$ 334.15 billion in 2021. The global healthcare BPO market is projected to reach US$ 755.76 billion by 2030, registering a compound annual growth rate (CAGR) of 9.49% during the forecast period from 2022 to 2030.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2014

The global healthcare BPO market report offers various segments analysis by size, trends, growth factors, opportunities and key country outlook to 2030. The report offers a detailed analysis and information as per healthcare BPO, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Healthcare BPO Market Report Scope 

The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Read Also@ Home Infusion Therapy Market Size to Hit Around US$ 65.2 billion by 2030

Some of the prominent players in the healthcare BPO market include:

• Accenture (Ireland)
• Access Healthcare (US)
• Akurate Management Solutions (US)
• Cognizant (US)
• Firstsource Solutions (India)
• GeBBS Healthcare Solutions (US)
• Genpact (US)
• HCL Technologies (India)
• IBM Corporation (US)
• Infosys BPM (India)
• Invensis Technologies (India)
• IQVIA (US)
• Lonza (Switzerland)
• Mphasis (India)
• NTT Data Corporation (Japan)
• Omega Healthcare (India)
• Parexel International (US)
• R1 RCM (US)
• Sutherland Global (US)
• Sykes Enterprises (US)
• Tata Consultancy Services (India)
• UnitedHealth Group (US)
• Wipro (India)
• WNS (Holdings) Limited (India)
• Xerox Corporation (US)

Healthcare BPO Market Segmentation

By Provider Service

• Revenue Cycle Management
• Patient Enrolments
• Patient Care
  • Medical Transcription
  • Medical Imaging
  • Device Monitoring

By Payer Service

• Claims Management
  • Claims Adjudication Services
  • Claims Settlement Services
  • Information Management Services
  • Claims Repricing
  • Claims Investigation Services
  • Claims Indexing Services
  • Fraud Detection & Management
• Product Development & Business Acquisition (PDBA)
• Member Management
• Provider Management
• Care Management
• Integrated Front-End Services and Back-office Operations
• Billing and accounts management services
• HR Services

By Life Science Service

• Manufacturing
• R&D
• Non-Clinical Services
  • Supply Chain Management & Logistics
  • Sales and Marketing Services
    • Forecasting
    • Performance Reporting
    • Analytics
    • Research
    • Marketing
  • Other Non-Clinical Services

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Key Questions are

• What are the key factors influencing the healthcare BPO market in each region?
• How much value will the global market generate by the end of the forecast period?
• What will be the CAGR of the global market between 2022 and 2030?
• What would be the Y-o-Y growth trend of the global market between 2022 and 2030?
• What is the future scope and current trends in technologies of the global market?
• What is the revenue of the global market based on segments?
• Which key strategies are used by top players of the global market?
• Which are the leading companies in the global market?
• What are the essential strategies by key stakeholders in the market to expand their geographic presence?
• What are the major advancements witnessed in the global market?

Research Objectives and Research Approach

The comprehensive report on the global healthcare BPO market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global healthcare BPO market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global healthcare BPO market in terms of type, application, region and others. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global market.

Why should you invest in this report?

If you are aiming to enter the global healthcare BPO market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for healthcare BPO are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare BPO Market 

5.1. COVID-19 Landscape: Healthcare BPO Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare BPO Market, By Provider Service

8.1. Healthcare BPO Market, by Provider Service, 2022-2030

8.1.1 Revenue Cycle Management

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Patient Enrolments

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Patient Care

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare BPO Market, By Payer Service

9.1. Healthcare BPO Market, by Payer Service, 2022-2030

9.1.1. Claims Management

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Product Development & Business Acquisition (PDBA)

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Member Management

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Provider Management

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Care Management

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Integrated Front-End Services and Back-office Operations

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Billing and accounts management services

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.8. HR Services

9.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare BPO Market, By Life Science Service 

10.1. Healthcare BPO Market, by Life Science Service, 2022-2030

10.1.1. Manufacturing

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. R&D

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Non-Clinical Services

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare BPO Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

Chapter 12. Company Profiles

12.1. Accenture (Ireland)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Access Healthcare (US)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Akurate Management Solutions (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cognizant (US)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Firstsource Solutions (India)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GeBBS Healthcare Solutions (US)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genpact (US)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. HCL Technologies (India)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. IBM Corporation (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Infosys BPM (India)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2014

Our Press Release@ https://www.precedenceresearch.com/press-releases

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com